Breaking News - The Fly

Open Search

DYAI

Dyadic International

$

()

Dyadic International files to sell 3.35M shares of common stock for holders

DYAI

4/24/2024 - 17:22pm

Dyadic International appoints Lucy as Chairman of board, changes to the board

DYAI

3/28/2024 - 08:42am

Dyadic International announces publication on study of C1 monoclonal antibody

DYAI

3/26/2024 - 08:33am

Dyadic International to showcase Dapibus system at Future Food Tech event

DYAI

3/21/2024 - 08:36am

Dyadic International enters strategic partnerhsip agreement with Rabian

DYAI

2/28/2024 - 08:34am

Dyadic International advances collaboration with IIBR

DYAI

2/21/2024 - 08:35am

Dyadic, Cygnus announce partnership to provide C1 HCP ELISA Assay

DYAI , MRVI

2/13/2024 - 08:40am

Dyadic International announces research, development collab agreement

DYAI

2/6/2024 - 08:40am

Dyadic International announces results from Phase 1 trial of DYAI-100

DYAI

11/29/2023 - 08:37am

Dyadic International's C1 platform to be used to produce vaccines in Africa

DYAI

11/20/2023 - 08:38am

Dyadic International appoints Doug Pace as EVP, business development

DYAI

10/9/2023 - 08:34am

Dyadic enters research collaboration with VIC at Massachusetts General Hospital

DYAI

10/5/2023 - 08:39am

Dyadic International, bYoRNA SAS enter development, commercialization agreement

DYAI

9/26/2023 - 08:38am

Dyadic International enters development, license agreement for Dapibus

DYAI

9/19/2023 - 08:02am

Dyadic International files to sell $50M of common stock

DYAI

8/9/2023 - 16:13pm